Tezosentan (an intravenous endothelin receptor A/B antagonist) reduces peripheral resistance and increases cardiac power therefore preventing a steep decrease in blood pressure in patients with congestive heart failure.
| Image |  |
|---|---|
| Description | scientific article published in August 2001 |
| Author/s |
author: Edo Kaluski Gad Cotter |
| Publication date | August 1, 2001 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |